Literature DB >> 13679823

IFN-gamma-producing effector CD8+ T cells and IL-10-producing regulatory CD4+ T cells in fixed drug eruption.

Yuichi Teraki1, Tetsuo Shiohara.   

Abstract

BACKGROUND: Although effector and regulatory T cells play roles in the progression and resolution of inflammatory diseases, respectively, little in vivo data exist regarding the T-cell dynamics in the pathogenesis of inflammatory skin diseases in humans.
OBJECTIVE: Our aim is to phenotypically and functionally characterize the T cells responsible for initiation and regulation of inflammatory events in fixed drug eruption (FDE) as a disease model to study the role of cytokines produced within the epidermis in the pathogenesis of inflammatory skin disease.
METHODS: By use of flow cytometry, we phenotypically and functionally characterized the intraepidermal T cells that persist as a stable population in resting (pigmented) FDE lesions and that are present in active FDE lesions.
RESULTS: In resting FDE lesions, most of the intraepidermal T cells were of the CD8 phenotype, most of which expressed cutaneous lymphocyte-associated antigen, alpha4beta1, CD11a, alphaEbeta7, and CD45RA but not CD27, CD62L, CCR4, or CCR7. This population selectively expressed CD122 but not CD25. Intracellular staining demonstrated that most intraepidermal CD8+ T cells were capable of producing IFN-gamma and TNF-alpha but produced little IL-2 and IL-4. On the other hand, in the FDE lesions that arose after challenge, a significant number of CD4+ T cells capable of producing IL-10 migrated into the lesional epidermis. Moreover, nearly 70% of the CD4+ T cells migrating into the lesional epidermis expressed CD25.
CONCLUSIONS: Effector IFN-gamma-producing CD8+ T cells and regulatory IL-10-producing CD4+ T cells might be responsible for the progression and resolution of FDE, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13679823     DOI: 10.1016/s0091-6749(03)01624-5

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  18 in total

Review 1.  The role of T cells in drug reaction.

Authors:  Andrea Cavani; Ornella De Pità
Journal:  Curr Allergy Asthma Rep       Date:  2006-02       Impact factor: 4.806

Review 2.  Fixed drug eruption: a prototypic disorder mediated by effector memory T cells.

Authors:  Yoshiko Mizukawa; Tetsuo Shiohara
Journal:  Curr Allergy Asthma Rep       Date:  2009-01       Impact factor: 4.806

Review 3.  Resident memory T cells in human health and disease.

Authors:  Rachael A Clark
Journal:  Sci Transl Med       Date:  2015-01-07       Impact factor: 17.956

Review 4.  The Role of Memory CD8+ T Cells in Vitiligo.

Authors:  Rebecca L Riding; John E Harris
Journal:  J Immunol       Date:  2019-07-01       Impact factor: 5.422

5.  Maximal Points of Head's Zone in Fixed Drug Eruption.

Authors:  Sang Sin Lee; Dong Kyun Hong; Myung Im; Young Lee; Young Joon Seo; Jeung Hoon Lee
Journal:  Ann Dermatol       Date:  2011-12-27       Impact factor: 1.444

Review 6.  Tissue-resident memory T cells in the skin.

Authors:  Samar Khalil; Tara Bardawil; Mazen Kurban; Ossama Abbas
Journal:  Inflamm Res       Date:  2020-01-27       Impact factor: 4.575

7.  Gone but not forgotten: lesional memory in psoriatic skin.

Authors:  Rachael A Clark
Journal:  J Invest Dermatol       Date:  2011-02       Impact factor: 8.551

8.  Regulation gone wrong: a subset of Sézary patients have malignant regulatory T cells.

Authors:  Rachael A Clark
Journal:  J Invest Dermatol       Date:  2009-12       Impact factor: 8.551

Review 9.  Skin-resident T cells: the ups and downs of on site immunity.

Authors:  Rachael A Clark
Journal:  J Invest Dermatol       Date:  2009-08-13       Impact factor: 8.551

10.  The Combined Utility of Ex Vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions.

Authors:  Jason A Trubiano; Kaija Strautins; Alec J Redwood; Rebecca Pavlos; Katherine C Konvinse; Ar Kar Aung; Monica A Slavin; Karin A Thursky; M Lindsay Grayson; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.